Eclipse affixes Conformatie Europeene (CE) marking to TMR:
This article was originally published in Clinica
Executive Summary
Eclipse Surgical Technologies has received European approval to affix CE marking to its TMR lasers for transmyocardial revascularisation. The company has shown that 85% of angina patients treated with transmyocardial revascularisation improved significantly six months after surgery in a clinical trial in the US. The system is sold in Europe by Sorin Biomedica Cardio.